GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $354,175,000 | +14.3% | 8,136,345 | +14.4% | 0.08% | +23.1% |
| Q1 2022 | $309,844,000 | +46.5% | 7,113,039 | +48.3% | 0.06% | +54.8% |
| Q4 2021 | $211,540,000 | +61.3% | 4,796,835 | +39.8% | 0.04% | +50.0% |
| Q3 2021 | $131,115,000 | -2.0% | 3,431,435 | +2.1% | 0.03% | -6.7% |
| Q2 2021 | $133,821,000 | +53.1% | 3,360,631 | +37.2% | 0.03% | +36.4% |
| Q1 2021 | $87,394,000 | -36.8% | 2,448,701 | -34.9% | 0.02% | -38.9% |
| Q4 2020 | $138,348,000 | +53.8% | 3,759,449 | +57.4% | 0.04% | +38.5% |
| Q3 2020 | $89,926,000 | -17.4% | 2,389,104 | -10.4% | 0.03% | -21.2% |
| Q2 2020 | $108,804,000 | -14.9% | 2,667,431 | -20.9% | 0.03% | -26.7% |
| Q1 2020 | $127,783,000 | -15.4% | 3,372,480 | +4.9% | 0.04% | +18.4% |
| Q4 2019 | $151,119,000 | +20.4% | 3,215,986 | +9.4% | 0.04% | +5.6% |
| Q3 2019 | $125,481,000 | +21.9% | 2,940,051 | +14.3% | 0.04% | +20.0% |
| Q2 2019 | $102,911,000 | -34.2% | 2,571,479 | -31.3% | 0.03% | -36.2% |
| Q1 2019 | $156,343,000 | +60.2% | 3,741,186 | +46.5% | 0.05% | +51.6% |
| Q4 2018 | $97,572,000 | -22.2% | 2,553,582 | -18.2% | 0.03% | -3.1% |
| Q3 2018 | $125,425,000 | +5.1% | 3,122,351 | +5.5% | 0.03% | 0.0% |
| Q2 2018 | $119,288,000 | -0.5% | 2,959,255 | -3.6% | 0.03% | +3.2% |
| Q1 2018 | $119,889,000 | +40.5% | 3,068,579 | +27.6% | 0.03% | +55.0% |
| Q4 2017 | $85,307,000 | -23.6% | 2,405,048 | -12.6% | 0.02% | -28.6% |
| Q3 2017 | $111,722,000 | -9.7% | 2,751,747 | -4.1% | 0.03% | -9.7% |
| Q2 2017 | $123,722,000 | -12.1% | 2,869,231 | -14.1% | 0.03% | -18.4% |
| Q1 2017 | $140,763,000 | +1.8% | 3,338,789 | -7.0% | 0.04% | 0.0% |
| Q4 2016 | $138,285,000 | -6.6% | 3,590,887 | +4.6% | 0.04% | -13.6% |
| Q3 2016 | $148,012,000 | +0.6% | 3,431,790 | +1.1% | 0.04% | -8.3% |
| Q2 2016 | $147,130,000 | +8.4% | 3,394,779 | +1.4% | 0.05% | +6.7% |
| Q1 2016 | $135,789,000 | +30.9% | 3,348,679 | +30.3% | 0.04% | +36.4% |
| Q4 2015 | $103,716,000 | +6.7% | 2,570,408 | +1.7% | 0.03% | 0.0% |
| Q3 2015 | $97,200,000 | +0.7% | 2,527,985 | +9.1% | 0.03% | +10.0% |
| Q2 2015 | $96,544,000 | -16.1% | 2,317,973 | -7.0% | 0.03% | -18.9% |
| Q1 2015 | $115,029,000 | +14.9% | 2,492,495 | +6.4% | 0.04% | +15.6% |
| Q4 2014 | $100,099,000 | -25.3% | 2,342,034 | -19.7% | 0.03% | -23.8% |
| Q3 2014 | $134,083,000 | -2.6% | 2,916,759 | +13.3% | 0.04% | -2.3% |
| Q2 2014 | $137,724,000 | -7.9% | 2,575,236 | -8.0% | 0.04% | -12.2% |
| Q1 2014 | $149,573,000 | -9.9% | 2,799,427 | -10.0% | 0.05% | -10.9% |
| Q4 2013 | $166,099,000 | +4.1% | 3,111,062 | -2.2% | 0.06% | -6.8% |
| Q3 2013 | $159,602,000 | +10.0% | 3,181,229 | +9.6% | 0.06% | +5.4% |
| Q2 2013 | $145,058,000 | +3.7% | 2,902,906 | -9.8% | 0.06% | -3.4% |
| Q4 2012 | $139,856,000 | -23.0% | 3,217,308 | -18.1% | 0.06% | -19.4% |
| Q3 2012 | $181,560,000 | +15.3% | 3,926,491 | +13.6% | 0.07% | +2.9% |
| Q2 2012 | $157,526,000 | +24.3% | 3,456,777 | +22.5% | 0.07% | +18.6% |
| Q1 2012 | $126,710,000 | – | 2,821,417 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |